tracking. In addition, Teleplus has developed a platform to keep non-critical Covid-19 patients in the comfort of their own homes. The company's unique and innovative Covid-19 approach significantly improves the management of patients and reduces the burden that has overwhelmed many hospitals, especially in the NY/NJ/PA region. Key points are as follows: Care Management focus on three primary chronic conditions Year 5 Annual Revenue, EBITDA Projections: $155 million, $40+ million Teleplus Healthcare previously raised $1.7 million and is now in the midst of a $2.3 million capital raise and will be c cash flow positive late Q42020 (or early Q12020) without the need for additional capital. To more fully implement the company's plans, a much larger capital raise ($10 million) is planned for later this year (or early 2021).